Exploration and evaluation of adverse event signals of droxidopa based on the FAERS database

Background This study aims to utilize the FDA's Adverse Event Reporting System (FAERS) for data analysis to explore the potential adverse events associated with Droxidopa in real-world settings, thereby providing reference information for clinical practice.